Clinical Trials Logo

Clinical Trial Summary

Pain relief after open inguinal hernia repair could be improved by administration of TAP block or ilioinguinal/iliohypogastric nerve block. It is unclear which one works better. The investigators hypothesize that doing TAP block closer to the middle of the abdomen would result in improved pain relief due to simultaneous block of ilioinguinal/iliohypogastric nerves.

Clinical Trial Description

This study is a prospective, open, randomized trial. Subjects will be randomized using a computer-generated table of random numbers into 2 groups to receive pre-incisional ipsilateral ultrasound-guided TAP block using classic or medial approach. Group assignments will be sealed in sequentially numbered, opaque envelopes that would be opened by an anesthesiologist performing the block. The research nurse, not involved with patient care after the subject signed written informed consent, will provide postoperative data collection. Study subjects and other anesthesia care providers will also be blinded to group allocation.

All patients will be premedicated with 1-2mg IV midazolam and 50-150 mcg IV fentanyl. In the OR, propofol infusion will be started at 75mcg/kg/hr and titrated for patient comfort. After patient is adequately sedated, ultrasound guided TAP block will be performed in all subjects using a linear 6-15MHz ultrasound probe on a portable ultrasound machine (SonoSite, Bothell, WA). Classic approach group will receive a TAP block as previously described (Hebbard P, 2007). For the medial approach, once the external oblique abdominal, the internal oblique abdominal, and the transversus abdominal muscles were visualized using the ultrasound transducer between the costal margin and the iliac crest at the level of the anterior axillary line (classic approach), the transducer would be moved medially to the point where internal oblique muscle disappears. The injection target area will be within 1 inch lateral to that point.

The place of needle insertion will be prepped with Chlorhexidine gluconate 2% antiseptic solution, and 21G 90-mm StimuQuik needle (Arrow International, Reading, PA) will be used to inject 20ml of Ropivacaine 0.5% in the proper place once it is identified. Each subject will receive local infiltration with 20ml of Lidocaine1% : Bupivacaine 0.25% 1:1 mix prior to the incision by the surgeon as well as 1000 mg of IV acetaminophen and 8 mg IV dexamethasone intraoperatively.

In the postanesthesia care unit (PACU), the patient will be asked to rate their pain at rest upon arrival and at regular intervals on a 0 to 10 numeric rating scale (NRS), where 0 means no pain and 10 is the worst pain imaginable. Hydromorphone 0.5 mg IV will be administered every 5 minutes to maintain an NRS pain score <4 of 10. In cases of postoperative nausea or vomiting, subjects will receive 4mg IV ondansetron, followed by 12.5 mg IV Diphenhydramine if necessary. The Aldrete Recovery Score will be used to transfer the patients from Phase I of recovery, which focuses on providing a transition from a totally anesthetized state to one requiring less intervention. Aldrete Scoring System assesses respiration, oxygen saturation, consciousness, circulation and activity. Each item is scored on a 0 to 2 scale with higher score representing more advanced recovery. Once the score of 9 or higher is reached, the subjects will be transferred to Phase II recovery, which focuses on preparing the patient for dicharge. At discharge, subjects will be instructed to take a combination of oxycodone 5mg and acetaminophen 325mg orally every 4-6 hours for NRS pain score>4 of 10. Postoperative opioid consumption for the 48 hours will be converted to an equivalent dose of oral hydromorphone.

Subjects will be contacted by telephone by a research nurse or one of the investigators not involved in their care, and will be asked about their pain and amount of pain medication they consumed since discharge or since the last phone call respectively. In case of a potential problem, the matter will be referred to a physician. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

NCT number NCT01589796
Study type Interventional
Source Stamford Anesthesiology Services, PC
Contact Vlad Frenk, MD
Phone 203 276-7490
Status Recruiting
Phase N/A
Start date April 2012

See also
  Status Clinical Trial Phase
Recruiting NCT02976272 - Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple N/A
Recruiting NCT01570465 - Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
Not yet recruiting NCT01209481 - Impact of Educational Group Intervention on the Consumption of Fruit and Vegetables N/A
Not yet recruiting NCT01943565 - Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study Phase 4
Completed NCT00519298 - Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects Phase 1
Completed NCT03541837 - Erector Spinae Plane Block and Pain Management in Cardiac Surgery N/A
Active, not recruiting NCT00809575 - Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
Not yet recruiting NCT03728114 - Effects of RIC on Cognitive Function and Blood Oxygen Levels in Unacclimatized Adult at High Altitude N/A
Recruiting NCT01817153 - Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock. Phase 2/Phase 3
Completed NCT01162863 - Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation N/A
Recruiting NCT03713931 - PUMA Implementation 2
Terminated NCT01375595 - Brain Areas Involved in Sound and Spoken Word Memory N/A
Recruiting NCT01593280 - TAP Catheters Versus Intrathecal Morphine for Cesarean Section N/A
Completed NCT01939925 - Communicating Evidence From Systematic Reviews to the Public N/A
Active, not recruiting NCT03632226 - Evaluation of a Novel PET Radioligand to Image OGA
Completed NCT02147392 - Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy People Early Phase 1
Recruiting NCT03335644 - The NutriNet-Santé Study N/A
Recruiting NCT00961285 - Genotyping Analysis of Acute Lymphoblastic Leukemia N/A
Active, not recruiting NCT03310814 - An Intervention to Develop Interface Tools for Nutrigenomics N/A
Completed NCT01175993 - Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adults With Traumatic Brain Injury Phase 1/Phase 2